These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1405383

  • 1. Risk of adynamic bone disease in dialyzed patients.
    Malluche HH, Monier-Faugere MC.
    Kidney Int Suppl; 1992 Oct; 38():S62-7. PubMed ID: 1405383
    [Abstract] [Full Text] [Related]

  • 2. Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies.
    Ballanti P, Wedard BM, Bonucci E.
    Nephrol Dial Transplant; 1996 Apr; 11(4):663-7. PubMed ID: 8671855
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for renal osteodystrophy: a multivariant analysis.
    Pei Y, Hercz G, Greenwood C, Segre G, Manuel A, Saiphoo C, Fenton S, Sherrard D.
    J Bone Miner Res; 1995 Jan; 10(1):149-56. PubMed ID: 7747622
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Variant of adynamic bone disease in hemodialysis patients: fact or fiction?
    Rocha LA, Higa A, Barreto FC, dos Reis LM, Jorgetti V, Draibe SA, Carvalho AB.
    Am J Kidney Dis; 2006 Sep; 48(3):430-6. PubMed ID: 16931216
    [Abstract] [Full Text] [Related]

  • 9. Renal osteodystrophy in patients on hemodialysis for more than 10 years.
    Piraino BM, Rault R, Dominguez JH, Puschett JB.
    Miner Electrolyte Metab; 1986 Sep; 12(5-6):390-6. PubMed ID: 3807834
    [Abstract] [Full Text] [Related]

  • 10. Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment?
    Cohen-Solal ME, Sebert JL, Boudailliez B, Westeel PF, Morinière PH, Marie A, Garabedian M, Fournier A.
    Bone; 1992 Sep; 13(1):1-5. PubMed ID: 1581102
    [Abstract] [Full Text] [Related]

  • 11. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Sep; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Low turnover bone disease is the more common form of bone disease in CAPD patients.
    Rodriguez-Perez JC, Plaza C, Torres A, Vega N, Anabitarte A, Fernandez A, Lorenzo V, Hortal L, Palop L.
    Adv Perit Dial; 1992 Sep; 8():376-80. PubMed ID: 1361827
    [Abstract] [Full Text] [Related]

  • 17. [Prevalence of histological types of bone disease in a hemodialysis center limiting the oral intake of aluminum hydroxide].
    Belbrik S, Marie A, Boudailliez B, Morinière P, Sébert JL, Solal MC, Westeel PF, Roche D, Fournier A.
    Nephrologie; 1990 Sep; 11(2):83-90. PubMed ID: 2392208
    [Abstract] [Full Text] [Related]

  • 18. Bone mineral and aluminum concentrations in patients undergoing CAPD.
    Giangrande A, Costanini S, Ballanti P, Castiglioni A, Caligara F, Pisoni B, Giordano R, Vernillo I, Berni S, Bonucci E.
    Adv Perit Dial; 1992 Sep; 8():351-5. PubMed ID: 1361821
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Renal osteodystrophy: pathogenesis and management.
    Gonzalez EA, Martin KJ.
    Nephrol Dial Transplant; 1995 Sep; 10 Suppl 3():13-21. PubMed ID: 7494608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.